Gimpayan, Caren Jane .

HRN: 16-22-11  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/28/2023
CEFUROXIME 750MG (VIAL)
09/28/2023
09/30/2023
IV
750 Mg
Q8
Thinly MSAF PROMX 2 Hrs
Rejected 
09/28/2023
CEFUROXIME 500MG (TAB)
09/28/2023
10/05/2023
PO
1 Tab
BID
SP NSVD W RMLE & Repair
Checking Final Appropriateness 
09/28/2023
METRONIDAZOLE 500MG (TAB)
09/28/2023
10/05/2023
PO
1 Tab
TID
SP NSVD W RMLE And Repair; Thinly MSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: